Advance Syntex Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 12, 2025, 12:17 am

Quick Insight

Advance Syntex Ltd, operating in the Packaging & Containers industry, currently trades at a price of 4.90 with a market capitalization of 5.44 Cr. The company's financial metrics reveal a negative net profit of -18 Cr, a P/BV ratio of -0.49x, and an ICR of -14.32x, indicating significant financial challenges. With reserves at -24 Cr and borrowings of ₹24 Cr, the company faces a precarious financial position. Moreover, the ROCE stands at a modest 1.46%, reflecting limited returns on capital employed. Investors should exercise caution due to the company's weak financial performance and consider the high level of risk associated with this investment.

Competitors of Advance Syntex Ltd

All Competitor Stocks of Advance Syntex Ltd

Quarterly Result

Last Updated: July 16, 2025, 3:01 pm

Below is a detailed analysis of the quarterly data for Advance Syntex Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Sales, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 0.00 Cr..
• For Expenses, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 0.00 Cr..
• For Operating Profit, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 0.00 Cr..
• For OPM %, as of Mar 2025, the value is 0.00%. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 0.00%.
• For Other Income, as of Mar 2025, the value is -18.00 Cr.. The value appears to be declining and may need further review. It has decreased from 0.00 Cr. (Dec 2024) to -18.00 Cr., marking a decrease of 18.00 Cr..
• For Interest, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 0.00 Cr..
• For Depreciation, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 0.00 Cr..
• For Profit before tax, as of Mar 2025, the value is -18.00 Cr.. The value appears to be declining and may need further review. It has decreased from 0.00 Cr. (Dec 2024) to -18.00 Cr., marking a decrease of 18.00 Cr..
• For Tax %, as of Mar 2025, the value is 0.00%. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 0.00%.
• For Net Profit, as of Mar 2025, the value is -18.00 Cr.. The value appears to be declining and may need further review. It has decreased from 0.00 Cr. (Dec 2024) to -18.00 Cr., marking a decrease of 18.00 Cr..
• For EPS in Rs, as of Mar 2025, the value is -15.79. The value appears to be declining and may need further review. It has decreased from -0.27 (Dec 2024) to -15.79, marking a decrease of 15.52.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: June 16, 2025, 3:12 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: July 25, 2025, 1:58 pm

Below is a detailed analysis of the balance sheet data for Advance Syntex Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 11.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 11.00 Cr..
• For Reserves, as of Mar 2025, the value is -24.00 Cr.. The value appears to be worsening (becoming more negative). It has deteriorated from -5.00 Cr. (Mar 2024) to -24.00 Cr., marking a decline of 19.00 Cr..
• For Borrowings, as of Mar 2025, the value is 24.00 Cr.. The value appears to be improving (decreasing). However, Reserves are negative, which is a major warning sign. It has decreased from 33.00 Cr. (Mar 2024) to 24.00 Cr., marking a decrease of 9.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 2.00 Cr.. The value appears to be improving (decreasing). It has decreased from 3.00 Cr. (Mar 2024) to 2.00 Cr., marking a decrease of 1.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 13.00 Cr.. The value appears to be improving (decreasing). It has decreased from 41.00 Cr. (Mar 2024) to 13.00 Cr., marking a decrease of 28.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 3.00 Cr. (Mar 2024) to 0.00 Cr., marking a decrease of 3.00 Cr..
• For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Investments, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Other Assets, as of Mar 2025, the value is 13.00 Cr.. The value appears to be declining and may need further review. It has decreased from 39.00 Cr. (Mar 2024) to 13.00 Cr., marking a decrease of 26.00 Cr..
• For Total Assets, as of Mar 2025, the value is 13.00 Cr.. The value appears to be declining and may need further review. It has decreased from 41.00 Cr. (Mar 2024) to 13.00 Cr., marking a decrease of 28.00 Cr..

However, the Borrowings (24.00 Cr.) are higher than the Reserves (-24.00 Cr.), which may signal higher financial risk.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Advance Syntex Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is -16.59. This value is below the healthy minimum of 5. It has decreased from -5.61 (Mar 24) to -16.59, marking a decrease of 10.98.
• For Diluted EPS (Rs.), as of Mar 25, the value is -16.59. This value is below the healthy minimum of 5. It has decreased from -5.61 (Mar 24) to -16.59, marking a decrease of 10.98.
• For Cash EPS (Rs.), as of Mar 25, the value is -16.37. This value is below the healthy minimum of 3. It has decreased from -5.24 (Mar 24) to -16.37, marking a decrease of 11.13.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is -11.19. It has decreased from 5.40 (Mar 24) to -11.19, marking a decrease of 16.59.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is -11.19. It has decreased from 5.40 (Mar 24) to -11.19, marking a decrease of 16.59.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 0.00. It has decreased from 0.67 (Mar 24) to 0.00, marking a decrease of 0.67.
• For PBDIT / Share (Rs.), as of Mar 25, the value is -0.11. This value is below the healthy minimum of 2. It has increased from -0.94 (Mar 24) to -0.11, marking an increase of 0.83.
• For PBIT / Share (Rs.), as of Mar 25, the value is -0.34. This value is below the healthy minimum of 0. It has increased from -1.31 (Mar 24) to -0.34, marking an increase of 0.97.
• For PBT / Share (Rs.), as of Mar 25, the value is -16.61. This value is below the healthy minimum of 0. It has decreased from -5.68 (Mar 24) to -16.61, marking a decrease of 10.93.
• For Net Profit / Share (Rs.), as of Mar 25, the value is -16.59. This value is below the healthy minimum of 2. It has decreased from -5.61 (Mar 24) to -16.59, marking a decrease of 10.98.
• For PBDIT Margin (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 10. It has increased from -140.23 (Mar 24) to 0.00, marking an increase of 140.23.
• For PBIT Margin (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 10. It has increased from -195.65 (Mar 24) to 0.00, marking an increase of 195.65.
• For PBT Margin (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 10. It has increased from -844.26 (Mar 24) to 0.00, marking an increase of 844.26.
• For Net Profit Margin (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 5. It has increased from -834.38 (Mar 24) to 0.00, marking an increase of 834.38.
• For Return on Networth / Equity (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 15. It has increased from -103.84 (Mar 24) to 0.00, marking an increase of 103.84.
• For Return on Capital Employeed (%), as of Mar 25, the value is 7.19. This value is below the healthy minimum of 10. It has increased from -8.27 (Mar 24) to 7.19, marking an increase of 15.46.
• For Return On Assets (%), as of Mar 25, the value is -137.20. This value is below the healthy minimum of 5. It has decreased from -15.06 (Mar 24) to -137.20, marking a decrease of 122.14.
• For Long Term Debt / Equity (X), as of Mar 25, the value is -0.56. This value is below the healthy minimum of 0.2. It has decreased from 1.93 (Mar 24) to -0.56, marking a decrease of 2.49.
• For Total Debt / Equity (X), as of Mar 25, the value is -1.96. This value is within the healthy range. It has decreased from 5.46 (Mar 24) to -1.96, marking a decrease of 7.42.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.00. It has decreased from 0.01 (Mar 24) to 0.00, marking a decrease of 0.01.
• For Current Ratio (X), as of Mar 25, the value is 0.55. This value is below the healthy minimum of 1.5. It has decreased from 1.51 (Mar 24) to 0.55, marking a decrease of 0.96.
• For Quick Ratio (X), as of Mar 25, the value is 0.55. This value is below the healthy minimum of 1. It has decreased from 0.58 (Mar 24) to 0.55, marking a decrease of 0.03.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 4. It has decreased from 0.01 (Mar 24) to 0.00, marking a decrease of 0.01.
• For Interest Coverage Ratio (X), as of Mar 25, the value is -14.32. This value is below the healthy minimum of 3. It has increased from -19.37 (Mar 24) to -14.32, marking an increase of 5.05.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is -39.68. This value is below the healthy minimum of 3. It has decreased from -25.66 (Mar 24) to -39.68, marking a decrease of 14.02.
• For Enterprise Value (Cr.), as of Mar 25, the value is 30.35. It has decreased from 39.42 (Mar 24) to 30.35, marking a decrease of 9.07.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 1. It has decreased from 52.83 (Mar 24) to 0.00, marking a decrease of 52.83.
• For EV / EBITDA (X), as of Mar 25, the value is -232.89. This value is below the healthy minimum of 5. It has decreased from -37.67 (Mar 24) to -232.89, marking a decrease of 195.22.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 1. It has decreased from 9.04 (Mar 24) to 0.00, marking a decrease of 9.04.
• For Price / BV (X), as of Mar 25, the value is -0.49. This value is below the healthy minimum of 1. It has decreased from 1.13 (Mar 24) to -0.49, marking a decrease of 1.62.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 1. It has decreased from 9.05 (Mar 24) to 0.00, marking a decrease of 9.05.
• For EarningsYield, as of Mar 25, the value is -3.02. This value is below the healthy minimum of 5. It has decreased from -0.92 (Mar 24) to -3.02, marking a decrease of 2.10.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness